Page last updated: 2024-10-28

hydrochlorothiazide and Hypertension, Renal

hydrochlorothiazide has been researched along with Hypertension, Renal in 88 studies

Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.

Hypertension, Renal: Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN.

Research Excerpts

ExcerptRelevanceReference
"Telmisartan (Micardis, Pritor), a highly selective angiotensin II (AII) type 1 (AT1) receptor antagonist, is approved for the treatment of hypertension, either as monotherapy or in combination with other antihypertensive agents."8.83Telmisartan: a review of its use in the management of hypertension. ( Battershill, AJ; Scott, LJ, 2006)
"The effect of long-term treatment of hypertension with propranolol, alone or in combination with hydrochlorothiazide and/or dihydralazine, was investigated in 93 patients with various types of hypertension."7.66[Long-term treatment of arterial hypertension with propranolol. Combination with diuretics and dihydrazinophthalazine]. ( Ambrosio, G; Corgnati, A; Dal Palù, C; Palatini, P; Pessina, AC, 1978)
"The objectives of this study were to compare the effects of the angiotensin II receptor blocker, losartan, to those of the angiotensin-converting enzyme inhibitor, enalapril, on albuminuria and renal function in relationship to clinic and ambulatory blood pressure (ABP) in hypertensive type 2 diabetic subjects with early nephropathy."5.09Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy. ( Bélanger, A; Godin, C; Hallé, JP; Lacourcière, Y; Marion, J; Ross, S; Wright, N, 2000)
"Telmisartan (Micardis, Pritor), a highly selective angiotensin II (AII) type 1 (AT1) receptor antagonist, is approved for the treatment of hypertension, either as monotherapy or in combination with other antihypertensive agents."4.83Telmisartan: a review of its use in the management of hypertension. ( Battershill, AJ; Scott, LJ, 2006)
"Hydrochlorothiazide (HCTZ) is used to manage hypertension and heart failure; however, its side effects include mild hypokalemia, metabolic abnormalities, and volume depletion, which might have deleterious effects on renal and endothelial function."3.74Thiazide-induced subtle renal injury not observed in states of equivalent hypokalemia. ( Byer, K; Croker, BP; Hu, H; Johnson, RJ; Mu, W; Nakagawa, T; Patel, JM; Reungjui, S; Roncal, CA; Simoni, J; Sitprija, V; Srinivas, T; Wesson, D, 2007)
"The effect of long-term treatment of hypertension with propranolol, alone or in combination with hydrochlorothiazide and/or dihydralazine, was investigated in 93 patients with various types of hypertension."3.66[Long-term treatment of arterial hypertension with propranolol. Combination with diuretics and dihydrazinophthalazine]. ( Ambrosio, G; Corgnati, A; Dal Palù, C; Palatini, P; Pessina, AC, 1978)
"Renal artery stenosis is among the most common curable causes of hypertension."2.70Resistance to antihypertensive medication as predictor of renal artery stenosis: comparison of two drug regimens. ( Deinum, J; Derkx, FH; Krijnen, P; Postma, CT; Schalekamp, MA; van Jaarsveld, BC; Woittiez, AJ, 2001)
"Amiloride treatment caused a 2-fold greater increase in Na(+) excretion in knockout, compared with WT."1.42Increased Epithelial Sodium Channel Activity Contributes to Hypertension Caused by Na+-HCO3- Cotransporter Electrogenic 2 Deficiency. ( Boettger, T; Cornelius, RJ; Li, H; Sansom, SC; Wang, B; Wang-France, J; Warner, PC; Wen, D; Yuan, Y, 2015)
" Pharmacokinetic-pharmacodynamic (PK/PD) modeling was applied to investigate the pharmacokinetic and pharmacodynamic interaction between irbesartan and HCTZ in renal hypertensive dogs at non-steady-state and steady-state."1.33Pharmacokinetic and pharmacodynamic interaction between irbesartan and hydrochlorothiazide in renal hypertensive dogs. ( Huang, XH; Li, J; Qiu, FR; Xie, HT, 2005)
"Perindopril was associated with significantly lower AER than lacidipine, whereas lacidipine was more potent in preventing increases in ocular AVC."1.29Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat. ( Cooper, M; Gin, T; Jerums, G; Joon, TL; Panagiotopoulos, S; Taylor, H, 1996)
"When nitrendipine was combined with thiazides, a lowering of plasma potassium levels could be found, which, however, did not necessitate any therapy."1.27Safety aspects of long-term nitrendipine therapy. ( Corsing, C; Deck, K; Ingram, C; Stoepel, K; Vanov, SK, 1984)
" Its effect is dosage dependent."1.25[Pharmacological and toxicological properties of the saluretic xipamide (4-chloro-5-sulfamoyl-2',6'-salicyloxylidide)]. ( Bahrmann, H; Leuschner, F; Neumann, W, 1975)

Research

Studies (88)

TimeframeStudies, this research(%)All Research%
pre-199068 (77.27)18.7374
1990's5 (5.68)18.2507
2000's13 (14.77)29.6817
2010's2 (2.27)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayashi, M1
Uchida, S1
Kawamura, T1
Kuwahara, M1
Nangaku, M1
Iino, Y1
Wen, D1
Yuan, Y1
Warner, PC1
Wang, B1
Cornelius, RJ1
Wang-France, J1
Li, H1
Boettger, T1
Sansom, SC1
Xie, HH1
Zhang, XF1
Chen, YY1
Shen, FM1
Su, DF1
Tiwari, S1
Li, L1
Riazi, S1
Halagappa, VK1
Ecelbarger, CM1
Handler, J1
TAKEUCHI, J1
TAKEDA, T1
UCHIDA, E1
OKADA, R1
SHINTANI, F1
SCHULTZ, J1
HOLTZ, M1
HAGEMANN, I1
LIU, JF1
LI, HY1
TING, KS1
SANCHETTI, P1
FAVERO, S1
LONGARETTI, A1
BELSITO, F1
SHULGA, IuD1
GIRALDI, A1
CHERIELIGNIERE, EL1
DIMARCO, N1
CASIROLA, G1
TARTARA, A1
CHERIE LIGNIERE, E1
PARDO, EG1
VIDRIO, H1
VARGAS, R1
GELFAND, ML1
GARREN, MG1
ROWAN, RL1
Griffin, KA1
Picken, MM1
Bidani, AK1
Soto, K1
Gómez-Garre, D1
Largo, R1
Gallego-Delgado, J1
Tejera, N1
Catalán, MP1
Ortiz, A1
Plaza, JJ1
Alonso, C1
Egido, J1
Minutolo, R1
De Nicola, L1
Zamboli, P1
Chiodini, P1
Signoriello, G1
Toderico, C1
Arfè, G1
Boschi, G1
Brancati, C1
Iaccarino, P1
Conte, G1
Huang, XH1
Qiu, FR1
Xie, HT1
Li, J1
Battershill, AJ1
Scott, LJ1
Reungjui, S1
Hu, H1
Mu, W1
Roncal, CA1
Croker, BP1
Patel, JM1
Nakagawa, T1
Srinivas, T1
Byer, K1
Simoni, J1
Wesson, D1
Sitprija, V1
Johnson, RJ1
Westhoff, JH1
Hilgers, KF1
Steinbach, MP1
Hartner, A1
Klanke, B1
Amann, K1
Melk, A1
Stoepel, K1
Deck, K1
Corsing, C1
Ingram, C1
Vanov, SK1
Bauer, JH3
Cushman, DW2
Ondetti, MA1
Cheung, HS1
Antonaccio, MJ2
Murthy, VS1
Rubin, B2
Sweet, CS3
Gross, DM1
Arbegast, PT1
Gaul, SL1
Britt, PM1
Ludden, CT1
Weitz, D1
Stone, CA1
Havelka, J1
Vetter, H2
Studer, A1
Greminger, P1
Lüscher, T1
Wollnik, S1
Siegenthaler, W1
Vetter, W1
Wenting, GJ1
de Bruyn, JH1
Man in't Veld, AJ1
Woittiez, AJ2
Derkx, FH2
Schalekamp, MA2
Roeckel, A1
Heidland, A1
Ribeiro, AB1
Alves Filho, G1
de Almeida, FA1
Kohlmann Junior, O1
Stella, SR1
Ramos, OL1
Chan, PS1
Ronsberg, MA1
Cervoni, P1
Emmerson, BT1
Renshaw, PJ1
Ravenscroft, PJ1
Denham, I1
Schey, S1
Amery, A1
Birkenhäger, W1
Bogaert, M1
Brixko, P1
Bulpitt, C1
Clement, D1
De Leeuw, P1
De Plaen, JF1
Deruyttere, M1
De Schaepdryver, A1
Fagard, R1
Forette, F1
Forte, J1
Hamdy, R1
Hellemans, J1
Henry, JF1
Koistinen, A1
Laaser, U1
Laher, M1
Leonetti, G1
Lewis, P1
Lund-Johansen, P1
MacFarlane, J1
Meurer, K1
Miguel, P1
Morris, J1
Mutsers, A1
Nissinen, A1
O'Brien, E1
Ohm, OJ1
O'Malley, K1
Pelemans, W1
Perera, N1
Tuomilehto, J1
Verschueren, LJ1
Willemse, P1
Williams, B1
Zanchetti, A1
Beretta, R1
Cassi, E1
Colombo, A1
De Paoli, A1
Marciandi, C1
Renzetti, GA1
Pessina, AC2
Hlede, M1
Pigato, R1
Palatini, P2
Dal Palù, C2
Juncos, LI1
Carrasco Dueñas, S1
Cornejo, JC1
Broglia, CA1
Cejas, H1
Gin, T1
Joon, TL1
Panagiotopoulos, S1
Cooper, M1
Taylor, H1
Jerums, G1
Schwenger, V1
Zeier, M1
Ritz, E1
Lottermoser, K1
Hertfelder, HJ1
Düsing, R1
Lacourcière, Y1
Bélanger, A1
Godin, C1
Hallé, JP1
Ross, S1
Wright, N1
Marion, J1
van Jaarsveld, BC1
Krijnen, P1
Deinum, J1
Postma, CT1
Finch, L1
Hicks, PE1
Moore, RA1
Gulati, OP1
Chakravarti, RN1
Sharma, PL1
Mandradjieff, M1
De Giorgio, LA1
Innocenti, F1
Bartolomei, GC1
Cade, R1
Juncos, L1
Tarrant, D1
Mahoney, J1
Raulerson, D1
Horovitz, ZP1
Panasevich, RE1
Inada, Y2
Nishikawa, K2
Nagaoka, A1
Kikuchi, S1
Corgnati, A1
Ambrosio, G1
Molnár, K1
Kömíves, S1
Kalmár, J1
Gerzon, J1
Gunnells, JC1
McGuffin, WL1
Depner, TA1
Sullivan, MJ1
Ryan, KG1
Winn, DF1
McCusker, JJ1
Yamauchi, H1
Leuschner, F1
Neumann, W1
Bahrmann, H1
DeForrest, JM1
Waldron, TL1
Harvey, C1
Scalese, B1
Mitch, S1
Powell, JR1
Petrillo, W1
Gurgenian, SV1
Mikaelian, ES1
Dzhandzhapanian, AZ1
Babaian, AS1
Anderson, S2
Rennke, HG2
Garcia, DL1
Brenner, BM2
Reams, GP2
Lal, SM1
Tanabe, M1
Kawazoe, K1
Gaddy, P1
Dworkin, LD1
Feiner, HD1
Randazzo, J1
Neugarten, J1
Kaminetsky, B1
Feiner, H1
Schacht, RG1
Liu, DT1
Baldwin, DS1
Schiffl, H2
Schollmeyer, P2
Bailey, DM1
DeGrazia, CG1
Wood, D1
Siggins, J1
Harding, HR1
Potts, GO1
Skulan, TW1
Peters, G1
Kubota, K1
Nicholas, TE1
Teichmann, G1
Löper, W1
Wenger, HC1
O'Malley, TA1
Fukuchi, S1
Nakajima, K1
Takenouchi, T1
Nishisato, K1
Kusumoto, M1
Constantopoulos, G1
Genest, J1
Ganten, D1
Ganten, U1
Rojo-Ortega, JM1
Boucher, R1
Freis, ED1
Spanos, PK1
Simmons, RL1
Kjellstrand, CM1
Buselmeier, TJ1
Najarian, JS1
Dargie, HJ1
Kennedy, AC1
Ward, DM1
Boddy, K1
King, PC1
Kim, KE1
Onesti, G1
Swartz, C1
Murphy, AV1
Paris, GL1
Macoul, KL1
Anderson, J1
Godfrey, BE1
Hill, DM1
Munro-Faure, AD1
Sheldon, J1
Sales, EJ1
Villa, JJ1
Mendez, MA1
Schubert, R1
Pasz, T1
Maebashi, M1
Yoshinaga, K1
Miura, K1
Goto, K1
Katsushima, I1
Cagli, V1
Ruotolo, V1
Bossini, A1
Bologna, E1
Frotscher, U1
Wilbrandt, R1
Piehl, W1
Freyland, MD1
Messerschmidt, W1
Pavesi, V1
Campus, G1
Glezer, GA1
Repetto, S1
Rezzonico, A1
Gervasini, N1
Anfossi, F1
Guaraggi, A1
Rossi, PL1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Uric Acid and Hypertension in African Americans[NCT00241839]Phase 3150 participants (Actual)Interventional2005-08-31Completed
Delaying the Progression of Diabetic Nephropathy in Pima Indians[NCT00353600]25 participants (Anticipated)Observational1994-08-19Completed
Renoprotection in Early Diabetic Nephropathy in Pima Indians[NCT00340678]Phase 3170 participants (Actual)Interventional1995-08-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Change in Diastolic Blood Pressure by Cuff 8-10 Weeks Minus Baseline

"The Diastolic BP was taken at Baseline and after 8-10 weeks of treatment or placebo while on chlorthalidone and potassium chloride. The blood pressure was measured according to Shared Care protocol: 15 minutes of quiet, undisturbed rest with three BP measurements obtained subsequently at 5 minute intervals.~The mean of the second and third reading was the value used for analysis for both the Baseline measurement and the measurement after 8 - 10 weeks of treatment. The dependent variable is baseline value minus ending value.~Measures are in millimeters of mercury (mm hg)" (NCT00241839)
Timeframe: Measured at 8-10 weeks on allopurinol / placebo

Interventionmm Hg (Mean)
A (Allopurinol)3.44
B (Placebo)-0.83

Change in Overall Mean BP From Those Obtained by 24 Hour Ambulatory Blood Pressure Measurements (ABPM) 8-10 Weeks Minus Baseline.

Subjects had 24 hr blood pressure monitoring (ABPM) at baseline and treatment end. The readings were averaged and the changes from baseline to treatment end were compared. (NCT00241839)
Timeframe: Baseline and end of treatment (8-10 weeks on allopurinol / placebo)

Interventionmm Hg (Mean)
A (Allopurinol)-5.9
B (Placebo)0.90

Change in Systolic Blood Pressure by Cuff After 8-10 Weeks Minus Baseline

"The systolic BP was taken at Baseline and after 8-10 weeks of treatment on placebo, while on chlorthalidone and potassium chloride. The blood pressure was measured according to Shared Care protocol: 15 minutes of quiet, undisturbed rest with three BP measurements obtained subsequently at 5 minute intervals.~The mean of the second and third reading was the value used for analysis for both the Baseline measurement and the measurement after 8 - 10 weeks of treatment. The dependent variable is baseline value minus ending value.~Measures are in millimeters of mercury (mm hg)" (NCT00241839)
Timeframe: Measured at 8-10 weeks on allopurinol or placebo

Interventionmm Hg (Mean)
A (Allopurinol)0.21
B (Placebo)-0.95

Change in Uric Acid (UA) Levels: Baseline Less End of Treatment

Subjects on allopurinol are expected to lower their uric acid levels relative to placebo. (NCT00241839)
Timeframe: Baseline UA levels compared to end of treatment levels (8-10 weeks on allopurinol / placebo)

Interventionmg/dl (Mean)
A (Allopurinol)2.29
B (Placebo)0.14

Glomerular Volume

(NCT00340678)
Timeframe: 6 years after first treatment

Intervention*10^6 cubic microns (Mean)
Normoalbuminuria Losartan5.4
Normoalbuminuria Placebo5.6
Microalbuminuria Losartan6.4
Microalbuminuria Placebo7.0

Number of Participants With Decline in GFR

Participants were monitored for up to 6 years. This is the number of participants who had a decline in GFR to less than or equal to 60 ml/min or to half the baseline value in subjects that enter the study with a GFR of less than 120 ml/min during the time of observation. (NCT00340678)
Timeframe: Up to 6 years

Interventionparticipants (Number)
Normoalbuminuria Losartan2
Normoalbuminuria Placebo2
Microalbuminuria Losartan1
Microalbuminuria Placebo4

Reviews

4 reviews available for hydrochlorothiazide and Hypertension, Renal

ArticleYear
Telmisartan: a review of its use in the management of hypertension.
    Drugs, 2006, Volume: 66, Issue:1

    Topics: Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Drug

2006
Role of angiotensin converting enzyme inhibitors in essential and renal hypertension. Effects of captopril and enalapril on renin-angiotensin-aldosterone, renal function and hemodynamics, salt and water excretion, and body fluid composition.
    The American journal of medicine, 1984, Aug-20, Volume: 77, Issue:2A

    Topics: Body Fluids; Captopril; Dipeptides; Drug Evaluation; Enalapril; Glomerular Filtration Rate; Hemodyna

1984
Low renin hypertension.
    Annual review of medicine, 1975, Volume: 26

    Topics: Adult; Age Factors; Diagnosis, Differential; Female; Humans; Hydrochlorothiazide; Hyperaldosteronism

1975
The treatment of hypertension. Why, when and how.
    The American journal of medicine, 1972, Volume: 52, Issue:5

    Topics: Arteriosclerosis; Cardiovascular Diseases; Diuretics; Female; Guanethidine; Humans; Hydralazine; Hyd

1972

Trials

11 trials available for hydrochlorothiazide and Hypertension, Renal

ArticleYear
Prospective randomized study of the tolerability and efficacy of combination therapy for hypertensive chronic kidney disease: results of the PROTECT-CKD study.
    Clinical and experimental nephrology, 2015, Volume: 19, Issue:5

    Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhi

2015
Ticrynafen and hydrochlorothiazide. A comparison in hypertensive patients with renal impairment.
    European journal of clinical pharmacology, 1982, Volume: 22, Issue:3

    Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Glycolates; Huma

1982
Antihypertensive therapy in patients above age 60 with systolic hypertension. A progress report of the European Working Party on High Blood Pressure in the Elderly (EWPHE).
    Clinical and experimental hypertension. Part A, Theory and practice, 1982, Volume: 4, Issue:7

    Topics: Aged; Blood Glucose; Blood Pressure; Creatinine; Drug Therapy, Combination; Electrolytes; Female; Hu

1982
Fibrinolytic function in diuretic-induced volume depletion.
    American journal of hypertension, 2000, Volume: 13, Issue:4 Pt 1

    Topics: Adult; Angiotensin II; Antihypertensive Agents; Blood Volume; Diuretics; Drug Therapy, Combination;

2000
Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy.
    Kidney international, 2000, Volume: 58, Issue:2

    Topics: Aged; Albuminuria; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Neph

2000
Resistance to antihypertensive medication as predictor of renal artery stenosis: comparison of two drug regimens.
    Journal of human hypertension, 2001, Volume: 15, Issue:10

    Topics: Adolescent; Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Cohort Studi

2001
Renal physiology and the treatment of hypertension.
    Comprehensive therapy, 1977, Volume: 3, Issue:1

    Topics: Blood Pressure; Body Weight; Clinical Trials as Topic; Depression, Chemical; Drug Therapy, Combinati

1977
Metabolic consequences of long-term thiazide-based antihypertensive treatment of renal hypertension.
    Cardiology, 1985, Volume: 72 Suppl 1

    Topics: Adolescent; Adult; Aged; Amiloride; Blood Glucose; Blood Pressure; Cholesterol; Coronary Disease; Dr

1985
Total body potassium in long-term Lasix therapy.
    Scottish medical journal, 1974, Volume: 19 Suppl 1

    Topics: Aldosterone; Clinical Trials as Topic; Diuresis; Furosemide; Humans; Hydrochlorothiazide; Hypertensi

1974
A comparison of the effects of hydrochlorothiazide and of frusemide in the treatment of hypertensive patients.
    The Quarterly journal of medicine, 1971, Volume: 40, Issue:160

    Topics: Adult; Aged; Blood Pressure; Blood Proteins; Carbon Dioxide; Clinical Trials as Topic; Female; Furos

1971
[Comparative mass studies on alpha-methyldopa (Presinol), Sali-Presinol and Cyclazenine in hypertensives of various origin].
    Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 1965, Volume: 71

    Topics: Adult; Aged; Clinical Trials as Topic; Female; Guanine; Humans; Hydrochlorothiazide; Hypertension; H

1965

Other Studies

73 other studies available for hydrochlorothiazide and Hypertension, Renal

ArticleYear
Increased Epithelial Sodium Channel Activity Contributes to Hypertension Caused by Na+-HCO3- Cotransporter Electrogenic 2 Deficiency.
    Hypertension (Dallas, Tex. : 1979), 2015, Volume: 66, Issue:1

    Topics: Amiloride; Animals; Antihypertensive Agents; Disease Models, Animal; Diuretics; Epithelial Sodium Ch

2015
Synergism of hydrochlorothiazide and nifedipine on blood pressure variability reduction and organ protection in spontaneously hypertensive rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2008, Volume: 31, Issue:4

    Topics: Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Calcium Channel Blockers; Drug Synergi

2008
Sex and age result in differential regulation of the renal thiazide-sensitive NaCl cotransporter and the epithelial sodium channel in angiotensin II-infused mice.
    American journal of nephrology, 2009, Volume: 30, Issue:6

    Topics: Age Factors; Aging; Angiotensin II; Animals; Blood Pressure; Diuretics; Epithelial Sodium Channels;

2009
Lithium and antihypertensive medication: a potentially dangerous interaction.
    Journal of clinical hypertension (Greenwich, Conn.), 2009, Volume: 11, Issue:12

    Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Antimanic Agents; Bipolar Disorde

2009
Vascular lesions in experimental renal hypertension, with special reference to effect of hypotensive treatment.
    Japanese heart journal, 1963, Volume: 4

    Topics: Arteries; Cerebral Hemorrhage; Coronary Vessels; Guanethidine; Humans; Hydralazine; Hydrochlorothiaz

1963
[The effect of prolonged administration of hydrochlorothiazide on the development of experimental renal hypertension and on electrolyte metabolism in rats].
    Acta biologica et medica Germanica, 1963, Volume: 10

    Topics: Animals; Chlorides; Electrolytes; Hydrochlorothiazide; Hypertension; Hypertension, Renal; Kidney; Po

1963
[EFFECTS OF 6 DRUGS ON THE PRODUCTION OF RENAL HYPERTENSION IN RATS].
    Yao xue xue bao = Acta pharmaceutica Sinica, 1962, Volume: 9

    Topics: Alkaloids; Bretylium Compounds; Hydrochlorothiazide; Hypertension; Hypertension, Renal; Pharmacology

1962
[CLINICAL STUDY OF A NEW COMPLEX HYPOTENSIVE DRUG COMBINATION].
    Gazzetta medica italiana, 1963, Volume: 122

    Topics: Antihypertensive Agents; Arteriosclerosis; Carbamates; Cerebrovascular Disorders; Coronary Disease;

1963
[CLINICAL RESEARCH WITH A COMPOUND HYPOTENSIVE PREPARATION (MEBUTAMATE + 1-4 DIHYDRAZINOPHTHALAZINE + DIHYDROCHLOROTHIAZIDE + POTASSIUM)].
    Gazzetta medica italiana, 1963, Volume: 122

    Topics: Antihypertensive Agents; Arteriosclerosis; Carbamates; Humans; Hydralazine; Hydrochlorothiazide; Hyp

1963
[APPLICATION OF HYPOTHIAZIDE IN CHRONIC KIDNEY DISEASES].
    Sovetskaia meditsina, 1963, Volume: 27

    Topics: Acute Kidney Injury; Blood Chemical Analysis; Glomerulonephritis; Hydrochlorothiazide; Hypertension;

1963
[ACTION OF ALPHA-METHYLDOPA IN COMBINATION WITH DIHYDROCHLOROTHIAZIDE ON RENAL HEMODYNAMICS IN HYPERTENSIVE SUBJECTS].
    Rivista di patologia e clinica, 1963, Volume: 18

    Topics: Antihypertensive Agents; Arteriosclerosis; Blood Circulation; Diuresis; Hemodynamics; Humans; Hydroc

1963
[ON THE ACTION OF TRIAMTERENE ON SALIDIURESIS CAUSED BY HYDROCHLOROTHIAZIDE].
    Gazzetta medica italiana, 1963, Volume: 122

    Topics: Ascites; Diuresis; Diuretics; Edema; Heart Failure; Hepatitis; Hydrochlorothiazide; Hypertension; Hy

1963
[CONTRIBUTION TO THE STUDY OF EXPERIMENTAL MODELS OF ARTERIAL HYPERTENSION].
    Gaceta medica de Mexico, 1964, Volume: 94

    Topics: Animals; Chlorisondamine; Classification; Cortisone; Dogs; Ganglionic Blockers; Hydrochlorothiazide;

1964
ACUTE ANURIA ASSOCIATED WITH CHLOROTHIAZIDE AND HYDROCHLOROTHIAZIDE THERAPY: RECOVERY.
    New York state journal of medicine, 1964, Jul-15, Volume: 64

    Topics: Acute Kidney Injury; Anuria; Chlorothiazide; Diabetes Mellitus; Digoxin; Geriatrics; Gout; Hydrochlo

1964
Blood pressure lability and glomerulosclerosis after normotensive 5/6 renal mass reduction in the rat.
    Kidney international, 2004, Volume: 65, Issue:1

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Enalapril; Glomeruloscl

2004
Tight blood pressure control decreases apoptosis during renal damage.
    Kidney international, 2004, Volume: 65, Issue:3

    Topics: Animals; Antihypertensive Agents; Apoptosis; Blood Pressure; Cell Division; Drug Therapy, Combinatio

2004
Management of hypertension in patients with CKD: differences between primary and tertiary care settings.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005, Volume: 46, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzy

2005
Pharmacokinetic and pharmacodynamic interaction between irbesartan and hydrochlorothiazide in renal hypertensive dogs.
    Journal of cardiovascular pharmacology, 2005, Volume: 46, Issue:6

    Topics: Animals; Biphenyl Compounds; Dogs; Drug Interactions; Drug Therapy, Combination; Hydrochlorothiazide

2005
Thiazide-induced subtle renal injury not observed in states of equivalent hypokalemia.
    Kidney international, 2007, Volume: 72, Issue:12

    Topics: Aldosterone; Animals; Blood Pressure; Body Weight; Diuretics; Hydrochlorothiazide; Hypertension, Ren

2007
Hypertension induces somatic cellular senescence in rats and humans by induction of cell cycle inhibitor p16INK4a.
    Hypertension (Dallas, Tex. : 1979), 2008, Volume: 52, Issue:1

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Antihypertensive Ag

2008
Safety aspects of long-term nitrendipine therapy.
    Journal of cardiovascular pharmacology, 1984, Volume: 6 Suppl 7

    Topics: Calcium Channel Blockers; Drug Therapy, Combination; Electrocardiography; Humans; Hydrochlorothiazid

1984
Inhibitors of angiotensin-converting enzyme.
    Advances in experimental medicine and biology, 1980, Volume: 130

    Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Binding, Competitiv

1980
Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitor.
    The Journal of pharmacology and experimental therapeutics, 1981, Volume: 216, Issue:3

    Topics: Administration, Oral; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihyperten

1981
Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension.
    The American journal of cardiology, 1982, Apr-21, Volume: 49, Issue:6

    Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Creatinine; Dose-R

1982
Hemodynamic effects of captopril in essential hypertension, renovascular hypertension and cardiac failure: correlations with short- and long-term effects on plasma renin.
    The American journal of cardiology, 1982, Apr-21, Volume: 49, Issue:6

    Topics: Blood Pressure; Captopril; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; H

1982
Acute and chronic renal effects of guanfacine in essential and renal hypertension.
    British journal of clinical pharmacology, 1980, Volume: 10 Suppl 1

    Topics: Antihypertensive Agents; Blood Pressure; Creatinine; Drug Therapy, Combination; Electrolytes; Glomer

1980
[Captopril in the clinical treatment of renovascular hypertension].
    AMB : revista da Associacao Medica Brasileira, 1980, Volume: 26, Issue:5

    Topics: Adult; Blood Pressure; Captopril; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hy

1980
Studies on the mechanism of the synergistic antihypertensive activity of captopril and hydrochlorothiazide following acute administration in spontaneously hypertensive rats.
    Clinical and experimental hypertension. Part A, Theory and practice, 1982, Volume: 4, Issue:6

    Topics: Animals; Captopril; Drug Synergism; Drug Therapy, Combination; Hydrochlorothiazide; Hypertension; Hy

1982
[Treatment of hypertensive states with a combination of alpha-methyldopa and a diuretic].
    La Clinica terapeutica, 1982, Dec-15, Volume: 103, Issue:5

    Topics: Adult; Aged; Antihypertensive Agents; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypert

1982
[Alpha-methyldopa and renal function in arterial hypertension].
    La Clinica terapeutica, 1980, May-15, Volume: 93, Issue:3

    Topics: Antihypertensive Agents; Clonidine; Dihydralazine; Humans; Hydrochlorothiazide; Hypertension; Hypert

1980
Long-term enalapril and hydrochlorothiazide in radiation nephritis.
    Nephron, 1993, Volume: 64, Issue:2

    Topics: Animals; Blood Pressure; Enalapril; Hydrochlorothiazide; Hypertension, Renal; Nephrectomy; Nephritis

1993
Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
    Investigative ophthalmology & visual science, 1996, Volume: 37, Issue:2

    Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Press

1996
Antihypertensive therapy in renal patients - benefits and difficulties.
    Nephron, 1999, Volume: 83, Issue:3

    Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive A

1999
Changes in vascular reactivity in experimental hypertensive animals following treatment with indapamide.
    The Journal of pharmacy and pharmacology, 1977, Volume: 29, Issue:12

    Topics: Animals; Blood Pressure; Brain; Cats; Desoxycorticosterone; Diuretics; Hydrochlorothiazide; Hyperten

1977
Comparative effect of spironolactone and hydrochlorothiazide therapy in experimental renal hypertension of Rhesus monkeys.
    The Indian journal of medical research, 1978, Volume: 67

    Topics: Animals; Female; Haplorhini; Hydrochlorothiazide; Hypertension, Renal; Macaca mulatta; Male; Spirono

1978
Enhancement of the antihypertensive effect of hydrochlorothiazide in dogs after suppression of renin release by beta-adrenergic blockade.
    Clinical science and molecular medicine, 1975, Volume: 48, Issue:2

    Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Dogs; Drug Synergism; Hydrochlorothiazide; Hyp

1975
[Antihypertensive effectiveness and tolerability of a combination of methyldopa and hydrochlorothiazide with and without potassium supplementation].
    Giornale di clinica medica, 1979, Volume: 60, Issue:9

    Topics: Adult; Aged; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Hydrochlorothiazide; Hyperte

1979
Influence of various antihypertensive agents on lifespan of renal hypertensive rats.
    British journal of clinical pharmacology, 1979, Volume: 7 Suppl 2

    Topics: Animals; Blood Pressure; Disease Models, Animal; Diuretics; Hydralazine; Hydrochlorothiazide; Hypert

1979
Comparison of the hypotensive and diuretic effects of 1,4-dimorpholino-7-phenylpyrido[3,4]pyridazine (DS-511) and hydrochlorothiazide in Doca, renal and spontaneously hypertensive rats.
    Arzneimittel-Forschung, 1977, Volume: 27, Issue:9

    Topics: Animals; Blood Pressure; Desoxycorticosterone; Diuretics; Hydrochlorothiazide; Hypertension; Hyperte

1977
[Long-term treatment of arterial hypertension with propranolol. Combination with diuretics and dihydrazinophthalazine].
    Minerva medica, 1978, Feb-11, Volume: 69, Issue:7

    Topics: Adult; Dihydralazine; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hydralazine; Hydro

1978
The use of the drug combination of hypothiazide+Visken+Halidor in hypertension.
    Therapia Hungarica (English edition), 1978, Volume: 26, Issue:3

    Topics: Adult; Bencyclane; Cycloheptanes; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hy

1978
Posttraumatic renal artery stenosis. Cure of hypertension by late revascularization.
    Archives of surgery (Chicago, Ill. : 1960), 1975, Volume: 110, Issue:9

    Topics: Abdominal Injuries; Accidents, Traffic; Adult; Aortography; Blood Pressure; Female; Humans; Hydrochl

1975
[Pharmacological and toxicological properties of the saluretic xipamide (4-chloro-5-sulfamoyl-2',6'-salicyloxylidide)].
    Arzneimittel-Forschung, 1975, Volume: 25, Issue:2

    Topics: Animals; Blood Glucose; Chlorides; Diuresis; Diuretics; Dogs; Dose-Response Relationship, Drug; Drug

1975
Blood pressure lowering and renal hemodynamic effects of fosinopril in conscious animal models.
    Journal of cardiovascular pharmacology, 1990, Volume: 16, Issue:1

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Desoxycorticosterone; Dogs; Female; Fosinopril; He

1990
Efficacy of intravenous verapamil in arterial hypertension refractory to three-step antihypertensive therapy.
    Cor et vasa, 1991, Volume: 33, Issue:5

    Topics: Adult; Antihypertensive Agents; Clonidine; Echocardiography; Female; Hemodynamics; Humans; Hydrochlo

1991
Short and long term effects of antihypertensive therapy in the diabetic rat.
    Kidney international, 1989, Volume: 36, Issue:4

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Diabetic Nephropathies; Drug Administra

1989
Short and long term effects of antihypertensive therapy in the diabetic rat.
    Kidney international, 1989, Volume: 36, Issue:4

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Diabetic Nephropathies; Drug Administra

1989
Short and long term effects of antihypertensive therapy in the diabetic rat.
    Kidney international, 1989, Volume: 36, Issue:4

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Diabetic Nephropathies; Drug Administra

1989
Short and long term effects of antihypertensive therapy in the diabetic rat.
    Kidney international, 1989, Volume: 36, Issue:4

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Diabetic Nephropathies; Drug Administra

1989
Renal protective effect of strict blood pressure control with enalapril therapy.
    Archives of internal medicine, 1987, Volume: 147, Issue:8

    Topics: Blood Pressure; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Humans; Hydrochloro

1987
Antihypertensive action of a new angiotensin converting enzyme inhibitor, (R)-3-[(S)-1-carboxy-5-(4-piperidyl)pentyl]amino-4-oxo-2,3,4,5-tetr ahy dro-1,5-benzothiazepine-5-acetic acid (CV-5975), in various hypertensive models.
    Japanese journal of pharmacology, 1988, Volume: 47, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Dogs; En

1988
Use of the converting enzyme inhibitor enalapril in renovascular hypertension. Effect on blood pressure, renal function, and the renin-angiotensin-aldosterone system.
    Hypertension (Dallas, Tex. : 1979), 1986, Volume: 8, Issue:4

    Topics: Angiography; Blood Pressure; Creatinine; Drug Therapy, Combination; Enalapril; Female; Glomerular Fi

1986
Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.
    The Journal of clinical investigation, 1986, Volume: 77, Issue:6

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Glomerular Filtration Rate; Hydralazin

1986
Glomerular hypertension and injury in desoxycorticosterone-salt rats on antihypertensive therapy.
    Kidney international, 1987, Volume: 31, Issue:3

    Topics: Animals; Blood Pressure; Capillaries; Desoxycorticosterone; Hydralazine; Hydrochlorothiazide; Hypert

1987
Nephrotoxic serum nephritis with hypertension: amelioration by antihypertensive therapy.
    Kidney international, 1985, Volume: 28, Issue:2

    Topics: Animals; Antihypertensive Agents; Dietary Proteins; Glomerular Filtration Rate; Hydralazine; Hydroch

1985
Clinical efficacy and safety of long-term diuretic treatment in renal parenchymal hypertension.
    International journal of clinical pharmacology, therapy, and toxicology, 1985, Volume: 23, Issue:11

    Topics: Adult; Aged; Amiloride; Blood Pressure; Cholesterol; Chronic Disease; Diuretics; Drug Therapy, Combi

1985
Amine functions of reduced basicity. Hypoglycemic and natriuretic alpha-alkoxybenzylamidoximes, amidines, and cycloamidines.
    Journal of medicinal chemistry, 1974, Volume: 17, Issue:7

    Topics: Amidines; Animals; Blood Glucose; Blood Pressure; Cats; Codeine; Dogs; Haplorhini; Hydrochlorothiazi

1974
Effects of val-5-angiotensin II-amide and of hydrochlorothiazide on the kidneys of renal hypertensive rats.
    Nephron, 1965, Volume: 2, Issue:2

    Topics: Angiotensin II; Animals; Desoxycorticosterone; Diuresis; Hydrochlorothiazide; Hypertension, Renal; I

1965
[Study on the renin-angiotensin-aldosterone system. Effects of sodium restriction and postural changes on plasma renin activity and fluctuation in urinary aldosterone].
    Japanese circulation journal, 1969, Volume: 33, Issue:3

    Topics: Aldosterone; Angiotensin II; Blood Pressure; Chromatography, Thin Layer; Diet, Sodium-Restricted; Hu

1969
Responses of mean arterial pressure to pressor agents and diuretics in renal hypertensive and salt hypertensive rats.
    British journal of pharmacology, 1971, Volume: 42, Issue:2

    Topics: Anesthesia, General; Angiotensin II; Animals; Arteries; Autonomic Nerve Block; Blood Pressure; Desox

1971
[Use, association and contraindications of hypotensive drugs].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1969, Jun-15, Volume: 24, Issue:12

    Topics: Antihypertensive Agents; Blood Pressure; Coronary Disease; Diuretics; Furosemide; Ganglionic Blocker

1969
Antagonism of hydrochlorothiazide-induced elevations in plasma-renin activity by methyldopa in conscious renal-hypertensive dogs.
    Canadian journal of physiology and pharmacology, 1974, Volume: 52, Issue:5

    Topics: Animals; Blood Pressure; Dogs; Female; Hydrochlorothiazide; Hypertension, Renal; Kidney; Male; Methy

1974
Plasma aldosterone in essential hypertension with low renin activity.
    Japanese circulation journal, 1974, Volume: 38, Issue:12

    Topics: Aldosterone; Body Weight; Corticosterone; Cushing Syndrome; Furosemide; Humans; Hydrochlorothiazide;

1974
Effects of hydrochlorothiazide on water, cation, and norepinephrine contents of cardiovascular tissues of renovascular hypertensive dogs.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1974, Volume: 147, Issue:3

    Topics: Animals; Aorta, Thoracic; Arteries; Blood Pressure; Blood Volume; Calcium; Carotid Arteries; Dogs; E

1974
Kidney transplantation from living related donors with multiple vessels. A problem revisited.
    American journal of surgery, 1973, Volume: 125, Issue:5

    Topics: Adolescent; Adult; Blood Pressure; Cadaver; Child; Child, Preschool; Creatinine; Female; Follow-Up S

1973
Problems in therapy for the hypertensive patient.
    Geriatrics, 1973, Volume: 28, Issue:3

    Topics: Antihypertensive Agents; Blood Pressure; Carotid Sinus; Diuretics; Electric Stimulation; Ethacrynic

1973
Value and toxicity of therapy for idiopathic nephrotic syndrome in the child.
    Nephron, 1973, Volume: 11, Issue:2

    Topics: Anti-Bacterial Agents; Blood Protein Disorders; Child; Chlorothiazide; Cyclophosphamide; Diet, Sodiu

1973
Reversible bullous retinal detachment in chronic renal disease.
    American journal of ophthalmology, 1969, Volume: 67, Issue:2

    Topics: Adult; Angiography; Diet; Female; Fluorescence; Humans; Hydrochlorothiazide; Hypertension, Renal; Hy

1969
[Treatment of essential and nephrogenic hypertension using alpha-methyldopa and alpha-methyldopa+hydrochlorothiazide. Comparative study].
    Prensa medica argentina, 1971, Jun-04, Volume: 58, Issue:14

    Topics: Administration, Oral; Adult; Aged; Female; Humans; Hydrochlorothiazide; Hypertension; Hypertension,

1971
Suppressed plasma renin activity in in hypertensive patients--its evaluation for the diagnosis of primary aldosteronism.
    The Tohoku journal of experimental medicine, 1969, Volume: 99, Issue:4

    Topics: Aldosterone; Cushing Syndrome; Diet, Sodium-Restricted; Glomerulonephritis; Humans; Hydrochlorothiaz

1969
[Renal excretion of uric acid in various conditions inducing hyperuricemia].
    Il Policlinico. Sezione pratica, 1970, Feb-23, Volume: 77, Issue:8

    Topics: Adolescent; Adult; Aged; Female; Gout; Humans; Hydrochlorothiazide; Hypertension, Renal; Kidney Fail

1970
[Influence of a combinated adelphan-esidrix and clonidin therapy on blood pressure and renal function in renal hypertension].
    Deutsche medizinische Wochenschrift (1946), 1971, Aug-27, Volume: 96, Issue:35

    Topics: Adult; Aniline Compounds; Blood Pressure Determination; Blood Urea Nitrogen; Drug Synergism; Female;

1971
[Results of hypotensive treatment in a hospital environment].
    Minerva medica, 1968, May-19, Volume: 59, Issue:40

    Topics: Adult; Aged; Arteriosclerosis; Carbamates; Female; Humans; Hydralazine; Hydrochlorothiazide; Hyperte

1968
[Effect of hypotensive substances (hypothiazide, guanetidine, alpha-methyldopa) on basic hemodynamic indices].
    Kardiologiia, 1968, Volume: 8, Issue:8

    Topics: Blood Pressure; Blood Volume; Cardiac Output; Cardiovascular System; Guanethidine; Hematocrit; Hemod

1968
[Considerations on ambulatory therapy in a group of hypertensive patients].
    Minerva medica, 1969, Jun-27, Volume: 60, Issue:51

    Topics: Adult; Aged; Ambulatory Care; Carbamates; Female; Guanethidine; Humans; Hydralazine; Hydrochlorothia

1969
[On the antihypertensive activity of some drugs alone or in various associations].
    Minerva cardioangiologica, 1966, Volume: 14, Issue:10

    Topics: Adult; Aged; Antihypertensive Agents; Arteriosclerosis; Carbamates; Female; Humans; Hydrazines; Hydr

1966